Peptide Regulatory Status
Understanding regulations across different countries
FDA Approved Peptides
FDA Regulatory Status
FDA Approved
Approved: May 13, 2022
Approved Indication:
Type 2 diabetes mellitus, chronic weight management
Clinical Trial Phase:
Phase 4 (Post-Marketing)
Approved as Mounjaro for diabetes. Approved as Zepbound for chronic weight management.
Regulatory History
FDA approval for chronic weight management (Zepbound)
Source: FDA.gov
FDA approval for Type 2 diabetes (Mounjaro)
Source: FDA.gov
FDA regulatory information is provided for informational purposes only and may not be current or complete. Regulations can change frequently. Always consult with FDA.gov and qualified regulatory experts for the most current information.
Peptides in Clinical Trials
Phase 4 (Post-Marketing)
Important Regulatory Disclaimer
Regulatory information provided on this site is for informational purposes only and may not be current, complete, or accurate. Peptide regulations vary by country and can change frequently. Always consult with local regulatory authorities, legal counsel, and healthcare professionals before purchasing, importing, or using peptides in your country. The information provided does not constitute legal or medical advice.
Understanding Regulatory Status
Approved
Peptide is approved for medical use in this country, typically requiring a prescription.
Research Only
Peptide is permitted for research purposes only, not for human consumption or therapeutic use.
Prescription Required
Peptide requires a valid prescription from a licensed healthcare provider.
Restricted
Peptide is restricted or controlled, with specific conditions for use or import.
Prohibited
Peptide is prohibited for import, sale, or use in this country.
Country-Specific Information
Regulatory status for each peptide is displayed on individual peptide pages. Select a country to view the current regulatory status and any relevant notes or restrictions.
For the most up-to-date information, always consult:
- Local regulatory authorities (FDA, Health Canada, MHRA, etc.)
- Customs and import regulations
- Licensed healthcare providers
- Legal counsel familiar with pharmaceutical regulations